Profil
Aurelia de Pauw currently works at TALLC Corp., Inc., as Director.
Dr. de Pauw also formerly worked at Tetra Bio-Pharma, Inc., as Vice President-Clinical Programs & Medical Affairs from 2019 to 2023.
Dr. de Pauw received her graduate degree in 2005 from Faculté Universitaire des Sciences Agronomiques de Gembloux and doctorate degree in 2005 from Université de Namur ASBL.
Anciens postes connus de Aurelia de Pauw
| Sociétés | Poste | Fin |
|---|---|---|
| TETRA BIO-PHARMA INC. | Corporate Officer/Principal | 01/05/2023 |
TALLC Corp., Inc.
TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology Operates as a pre-clinical stage pharmaceutical company, which develops drugs as anti-inflammatory and analgesic medicines | Directeur/Membre du Conseil | - |
Formation de Aurelia de Pauw
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Tetra Bio-Pharma, Inc.
Tetra Bio-Pharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development and growing pipeline of biopharmaceuticals, natural health and veterinary products | Health Technology |
Faculté Universitaire des Sciences Agronomiques de Gembloux
Faculté Universitaire des Sciences Agronomiques de Gembloux Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université de Namur ASBL
Université de Namur ASBL Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TALLC Corp., Inc.
TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology Operates as a pre-clinical stage pharmaceutical company, which develops drugs as anti-inflammatory and analgesic medicines | Health Technology |
















